| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic
|
Rastegar, Mehdi
|
|
|
39 |
3 |
p. 495-504
|
artikel
|
| 2 |
Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models
|
Schmit, Taylor
|
|
|
39 |
3 |
p. 469-472
|
artikel
|
| 3 |
BCG vaccine: Worrying proposal for COVID-19
|
Sarinho, Emanuel
|
|
|
39 |
3 |
p. 460-462
|
artikel
|
| 4 |
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy
|
Holm, Michelle R.
|
|
|
39 |
3 |
p. 457-459
|
artikel
|
| 5 |
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™)
|
Montgomery, Vicki A.
|
|
|
39 |
3 |
p. 564-570
|
artikel
|
| 6 |
“Does Pakistan still have polio cases?”: Exploring discussions on polio and polio vaccine in online news comments in Pakistan
|
Ittefaq, Muhammad
|
|
|
39 |
3 |
p. 480-486
|
artikel
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
3 |
p. IFC
|
artikel
|
| 8 |
Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally
|
Fan, Shengtao
|
|
|
39 |
3 |
p. 596-604
|
artikel
|
| 9 |
Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d
|
Kim, Kiju
|
|
|
39 |
3 |
p. 529-535
|
artikel
|
| 10 |
Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model
|
Ramakrishnan, A.
|
|
|
39 |
3 |
p. 487-494
|
artikel
|
| 11 |
Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats
|
Castaño-Zubieta, M. Raquel
|
|
|
39 |
3 |
p. 617-625
|
artikel
|
| 12 |
Global production capacity of seasonal and pandemic influenza vaccines in 2019
|
Sparrow, Erin
|
|
|
39 |
3 |
p. 512-520
|
artikel
|
| 13 |
HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC
|
Fulvini, Andrew A.
|
|
|
39 |
3 |
p. 545-553
|
artikel
|
| 14 |
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations
|
Greter, Helena
|
|
|
39 |
3 |
p. 580-587
|
artikel
|
| 15 |
Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials
|
Stevens, Vanessa W.
|
|
|
39 |
3 |
p. 536-544
|
artikel
|
| 16 |
Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant
|
Zhao, Xinxin
|
|
|
39 |
3 |
p. 588-595
|
artikel
|
| 17 |
IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice
|
Cibulski, Samuel
|
|
|
39 |
3 |
p. 571-579
|
artikel
|
| 18 |
Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination
|
Aparecido Nunes, Altacílio
|
|
|
39 |
3 |
p. 605-616
|
artikel
|
| 19 |
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity
|
Douglass, Nicola
|
|
|
39 |
3 |
p. 463-468
|
artikel
|
| 20 |
Physicians’ decision processes about the HPV vaccine: A qualitative study
|
Bouchez, Maité
|
|
|
39 |
3 |
p. 521-528
|
artikel
|
| 21 |
Preferences for a COVID-19 vaccine in Australia
|
Borriello, Antonio
|
|
|
39 |
3 |
p. 473-479
|
artikel
|
| 22 |
Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines
|
Bravo-Grande, José L.
|
|
|
39 |
3 |
p. 554-563
|
artikel
|
| 23 |
Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data
|
Marchal, Clarisse
|
|
|
39 |
3 |
p. 505-511
|
artikel
|
Tijdschrift beschrijving